Biography
Current Titles
- Director, Lipid Disorders Department
- Professor of Pediatrics, Medical School, National & Kapodistrian University of Athens (NKUA)
- Coordinator at the Registry of children with familial hypercholesterolemia (Hellas-FH Registry) at the Children’s Hospital “P. & A. Kyriakou”
Research Interest
- Lipid Disorders (Hyperlipidemias & hypolipidemias)
- Metabolic diseases from the perspective of the pediatrician
- Infections, especially zoonotic
Professional Experience
Full-time Pediatrician for 38 consecutive years (1985-2022) at:
- 1st Department of Pediatrics, Medical School, National and Kapodistrian University of Athens (NKUA), “Agia Sofia” Children’s Hospital
- 2nd Department of Pediatrics, “P. & A. Kyriakou” Children’s Hospital
- 2nd Department of Pediatrics, Medical School, NKUA, “P. & A. Kyriakou” Children’s Hospital, as a faculty member (2003 -2022), from the rank of Lecturer to the rank of Professor of Pediatrics
- Director, Athens Euroclinic, Department of Lipid Disorders, 2022
Medical Degree
Medical School, National and Kapodistrian University of Athens (1978)
Pediatrics – 1st Department of Pediatrics, Medical School, National and Kapodistrian University of Athens (NKUA) (1985)
- Attending International and Hellenic seminars mainly related to nutrition, lipid disorders and inborn errors of metabolism
- Member of the Hellenic Pediatric Society (1985)
- Regular member of the European Society of Pediatric Research (ESPR) (2000)
- Member of the Hellenic Atherosclerosis Society (2016)
- Member of the European Atherosclerosis Society (EAS) (2019)
- Founding member of the Hellenic Society of Pediatric Infections ( 2000)
- Member of Hellenic Society of the Study of Inborn Errors of metabolism (HSSIEM)
- Founding Member of the Society for Education and Research in Pediatrics of the 2nd Department of Pediatrics of NKUA
- Reviewer in International Scientific Medical Journals
- Reviewer of papers published in the Hellenic journal “PEDIATRICS”, announced at pediatric conferences and Intensive Seminars in Adolescent Medicine
- Member of the Scientific Program Committee (SPC) of the 34th – 37th Annual Panhellenic Medical Conference
- Member of the Scientific Committee of the Annual Intensive Seminars of the Adolescent Health Unit (State of the Art: Adolescent Medicine Course)
- Member of the Coordinating Committee of “Developmental and Adolescent Health Strategies” postgraduate programs
- English
- 2nd prize for applied research at the 19th Panhellenic Medical Conference, Athens 1993. Title: “Atrial natriuretic peptide in children with cystic fibrosis”
- Best Abstract Award, 2nd Excellence in Pediatrics Conference, 2-4 December 2010, London. Title: “Effectiveness of dietary plant sterols on lowering LDL-Cholesterol in children and adolescents.”
- 1st Prize at the 19th Panhellenic Congress of Lipidiology, Atherosclerosis and Vascular Disease, Athens 2016. Title: “The effect of atorvastatin administration on fasting insulin levels and growth rate in children with heterozygous familial hypercholesterolemia”
- 1st Prize for Best Announcement at the 7th Panhellenic Working Group Symposium 1-2/12/2017. Title: “Cardiovascular profile and treatment of patients with familial hypercholesterolemia in Greece: Preliminary data from the HELLAS-FH registry”
- 1st Prize for best announcement at the 8th Panhellenic Educational Seminar, Institute of Study Research & Education on Diabetes Mellitus and Metabolic Diseases 23-25/3/2018. Title: “Familial Hypercholesterolemia and Cardiovascular Disease: Preliminary Data from the HELLAS-FH Patient Registry”.
- 1st Prize for best announcement at the 9th Panhellenic Educational Seminar, Institute of Study Research & Education on Diabetes Mellitus and Metabolic Diseases 4/5/2019. Title: “Cardiovascular characteristics of adult patients with familial hypercholesterolemia: Latest data from the Hellenic Registry HELLAS-FH”.
- 1st Prize for best communication at the 8th Panhellenic Working Group Symposium, 29-30/11/2019, Title: “Familial hypercholesterolemia and newer European guidelines for dyslipidemias 2019: Clinical practice data from the Greek registry HELLAS-FH”
- Commendation award at the 8th Panhellenic Working Group Symposium, 29-30/11/2019, Athens. Title: “The effect of atorvastatin on the carotid intima – media thickness of children with dyslipidemia”.
- 2nd Clinical Research Award from the Hellenic Atherosclerosis Society. 9th Panhellenic Conference of the Hellenic Atherosclerosis Society Under the auspices of the European Atherosclerosis Society 3-5/12/2020. Title: “Achieving lipid targets and the role of PCSK9 inhibitors in the treatment of patients with familial hypercholesterolemia: Latest data from the Hellas -FH Greek Registry”.
- 156 publications in SCI journals, 82 full articles & 84 in abstract form, with many of them concerning lipid disorders and other risk factors for early atherosclerotic disease in children, adolescents and adults.
- More than 1400 Bibliographic References /Citations (Google Scholar)
- 53 publications, 31 full articles & 22 in summary form, in Greek medical journals and Honorary Volumes
- 307 announcements in 140 conferences, symposia, and other scientific meetings, of which 110 in 70 international and 197 in 70 Greek meetings.
- Publications on Lipid Disorders & Other Atherosclerotic CVD Risk Factors (2006-2022)
- Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Research 2006;70 (2-3): 211-17
- Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Research 2006 Oct;71(2-3): 229-32
- Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: A prospective long-term study. Eur J Paediatr Neurol 2006; 10 (5-6): 237-240.
- Thyroid dysfunction associated with increased low density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship? Eur J Paediatr Neurol 2007;11:358-361.
- Adiposity, blood pressure and carotid intima-media thickness in Greek adolescents. Obesity 2013;21(5):1013-7.
- Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long term study. Eur J Neurol 2013;21(1):118-123.
- Plant sterols–enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia. A prospective study. Ital J Pediatrics 2014;40:42.
- The role of Asymmetric Dimethylarginine and Lipoprotein-associated phospholipase A2 in children and adolescents with dyslipidemia. Original article. Health 2014. DOI 10.4236/health.2014.612177.
- Comparing calculated LDL-C with directly measured LDL-C in healthy and in dyslipidemic children. Clin Biochem. 2017 Jan;50(1-2):16-22.
- Associations between obesity, adverse behavioral patterns and cardiovascular risk factors among adolescent inhabitants of a Greek island. J Pediatr Endocrinol Metab. 2017;30(4):445-454.
- Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.. Atherosclerosis 2017 Oct;265:124-132
- An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Hormones (Athens). 2017 Jul;16(3):200-204.
- Influence of hypercholesterolemia on serum antibodies against oxidized LDL in children and adolescents. Pediatrics International 2018; Mar;60(3):287-293.
- Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Atherosclerosis 2018 Oct;277:308-313
- Overview of the current status of familial hypercholesterolaemia in over 60 countries – The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis 2018; 277:234-255.
- Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study. J Clin Neurol. 2019 Apr;15(2):149-151.
- Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study. Epilepsy Research 2019; 155:106162.
- Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH Registry. Lipids in Health and Disease 2020;19 (1):114.
- Lipoprotein apheresis: A Hellenic consensus on its clinical use. Hellenic J Cardiol. 2020 Letter to the editor Dec 31:S1109-9666(20)30292-X.
- The effect of long-term atorvastatin therapy on carotid intima-media thickness of children with dyslipidemia. Angiology. 2021 Apr;72(4):322-331.
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). 2021 Sep 7:S0140-6736(21)01122-3.
- LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments. Int J Cardiol. 2021 Oct 20:S0167-5273(21)01578-3.
- Cardiovascular risk factors and subclinical atherosclerosis in adolescents with Polycystic Ovary Syndrome (PCOS): its relationship with body mass index. Children (Basel) 2021; 9(1):4.
- Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH” Endocrine 2022; ;76 (2): 324-330.
- Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study. Children (Basel)2022 Jun 19;9(6):916.
- Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study. J Clin Neurol. 2019 Apr;15(2):149-151.
- Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study. Epilepsy Research 2019; 155:106162.
- Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH Registry. Lipids in Health and Disease 2020;19 (1):114.
- Lipoprotein apheresis: A Hellenic consensus on its clinical use. Hellenic J Cardiol. 2020 Letter to the editor Dec 31:S1109-9666(20)30292-X.
- The effect of long-term atorvastatin therapy on carotid intima-media thickness of children with dyslipidemia. Angiology. 2021 Apr;72(4):322-331.
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). 2021 Sep 7:S0140-6736(21)01122-3.
- LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments. Int J Cardiol. 2021 Oct 20:S0167-5273(21)01578-3.
- Cardiovascular risk factors and subclinical atherosclerosis in adolescents with Polycystic Ovary Syndrome (PCOS): its relationship with body mass index. Children (Basel) 2021; 9(1):4.
- Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH” Endocrine 2022; ;76 (2): 324-330.
- Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study. Children (Basel)2022 Jun 19;9(6):916.
Department
- Lipid Disorders Departement
Contact
Athens Euroclinic
7-9 Athanasiadou Street, Athens 115 21
Tel: +30 210 6416600
Appointments: +30 210 6416800 & 210 6416801
Fax: +30 210 6416555
e-mail: garoufi.lipids@yahoo.com
website: www.garoufi.gr